Alnylam Pharmaceuticals Inc (ALNY)

245.50 +6.63 (+2.78%) USD  |  NASDAQ  |  Dec 20, 16:00
245.46 -0.04 (-0.02%) After-Hours: 20:00
More

Alnylam Pharmaceuticals EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Pfizer Inc Upgrade
BridgeBio Pharma Inc --
Gilead Sciences Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Sarepta Therapeutics Inc --